In 2021, AU-3S and the MHRA (as a technical partner) successfully ran a capacity strengthening programme of 5 modules covering the end-to-end PV process. These sessions were aimed at strengthening safety surveillance capacities and were recommended to anyone involved or interested in effectively monitoring the safety of medical products. The focus was on safety surveillance in general, however specific considerations for COVID-19 vaccines were raised and discussed where relevant.
The training programme consisted of five training modules which were successfully run as live webinar sessions between January – May 2021. These sessions were recorded and have now been made available for further use. Each live session saw between 100 – 250 attendees in participation, with 75% of individuals rating their experience as either very good or excellent on average across all thirteen completed sessions. A consolidated set of the training recordings, presentations, and Q&A documents has been made available for further use and distribution by all countries or organisations.
The recordings and associated learning materials for all AU-3S capacity strengthening training sessions can be accessed via the AUDA-NEPAD e-Learning portal. One does not need to create an account to access the AU-3S training page on the portal, rather simply select the option “Click here to login as guest”.
The topics covered by each of the sessions can be seen in the table below, which also includes hyperlinks to access the respective module or training recording and download any related resource documents. For any questions or comments, please feel free to reach out to the AU-3S Team by mail using AU3S@nepad.org.
Title |
Contents |
MODULE 1Data collection |
|
MODULE 2Signal detection and management
|
|
MODULE 3Benefit risk assessment |
|
MODULE 4Safety communication |
|
MODULE 5Pharmacovigilance Expert Advisory Committee |
|